Education
About Us
Working with TipRanks
Follow Us
Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
Total Valuation
Connect Biopharma Holdings has a market cap or net worth of $101.71M. The enterprise value is -$16.51M.
Market Cap$101.71M
Enterprise Value-$16.51M
Share Statistics
Connect Biopharma Holdings has 55,721,657 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,721,657
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Connect Biopharma Holdings’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -24.46%.
Return on Equity (ROE)-0.17
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-24.46%
Return on Capital Employed (ROCE)-0.24
Revenue Per Employee419.89K
Profits Per Employee-252.06K
Employee Count62
Asset Turnover0.26
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Connect Biopharma Holdings is ―. Connect Biopharma Holdings’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value0.83
Price to FCF―
Price to Operating Cash Flow-4.24
PEG Ratio―
Income Statement
In the last 12 months, Connect Biopharma Holdings had revenue of 26.03M and earned -15.63M in profits. Earnings per share was -0.28.
Revenue26.03M
Gross Profit26.03M
Operating Income-22.45M
Pretax Income-15.40M
Net Income-15.63M
EBITDA-21.79M
Earnings Per Share (EPS)-0.28
Cash Flow
In the last 12 months, operating cash flow was -28.17M and capital expenditures -615.08K, giving a free cash flow of -28.78M billion.
Operating Cash Flow-28.17M
Free Cash Flow-28.78M
Free Cash Flow per Share-0.52
Dividends & Yields
Connect Biopharma Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change83.33%
50-Day Moving Average1.63
200-Day Moving Average1.09
Relative Strength Index (RSI)49.68
Average Volume (3m)218.76K
Important Dates
Connect Biopharma Holdings upcoming earnings date is Mar 26, 2026, After Close (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Connect Biopharma Holdings as a current ratio of 11.46, with Debt / Equity ratio of 0.19%
Current Ratio11.46
Quick Ratio11.46
Debt to Market Cap<0.01
Net Debt to EBITDA3.58
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Connect Biopharma Holdings has paid 223.00K in taxes.
Income Tax223.00K
Effective Tax Rate-0.01
Enterprise Valuation
Connect Biopharma Holdings EV to EBITDA ratio is 0.09, with an EV/FCF ratio of 0.08.
EV to Sales-0.07
EV to EBITDA0.09
EV to Free Cash Flow0.08
EV to Operating Cash Flow0.08
Balance Sheet
Connect Biopharma Holdings has $71.77M in cash and marketable securities with $870.00K in debt, giving a net cash position of -$70.90M billion.
Cash & Marketable Securities$71.77M
Total Debt$870.00K
Net Cash-$70.90M
Net Cash Per Share-$1.27
Tangible Book Value Per Share$1.67
Margins
Gross margin is 97.47%, with operating margin of -86.24%, and net profit margin of -60.03%.
Gross Margin97.47%
Operating Margin-86.24%
Pretax Margin-59.17%
Net Profit Margin-60.03%
EBITDA Margin-83.71%
EBIT Margin-86.24%
Analyst Forecast
The average price target for Connect Biopharma Holdings is $6.83, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.83
Price Target Upside265.24% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―